• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by MannKind

< Previous 1 2 3 Next >
News headline image
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
March 05, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Announces Participation at Upcoming Conferences
March 04, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
February 27, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
February 20, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
February 15, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
January 02, 2024
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Reports 2023 Third Quarter Financial Results
November 07, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
November 06, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
October 31, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
October 30, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Announces Participation at Upcoming Conferences
September 05, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Reports 2023 Second Quarter Financial Results
August 07, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference
August 01, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023
July 31, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)
June 22, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer
May 24, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
May 10, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results
May 09, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
Mannkind Corporation Reports 2023 First Quarter Financial Results
May 09, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Hold 2023 First Quarter Financial Results Conference Call on May 9, 2023
May 02, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer
March 27, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
February 23, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
February 22, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
February 16, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
February 10, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
January 24, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
January 23, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
News headline image
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
January 05, 2023
From MannKind
Via GlobeNewswire
Tickers MNKD
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap